2-SUBSTITUTED IMIDAZO[4,5-D]PHENANTHROLINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER
申请人:Aptose Biosciences Inc.
公开号:US20160031883A1
公开(公告)日:2016-02-04
The present invention provides 2-substituted imidazo[4,5-d]phenanthroline compounds, which are capable of inhibiting proliferation of one or more renal cancer cells, pancreatic cancer cells, prostate cancer cells, colon cancer cells, leukemia cells, brain cancer/tumour cells or non-small cell lung cancer cells.
本发明提供了2-取代的咪唑并[4,5-d]菲啰啉化合物,其能够抑制一个或多个肾癌细胞、胰腺癌细胞、前列腺癌细胞、结肠癌细胞、白血病细胞、脑癌/肿瘤细胞或非小细胞肺癌细胞的增殖。